|
|
|
SB1418 Engrossed |
|
LRB095 04444 RLC 24489 b |
|
|
1 |
| AN ACT concerning criminal law.
|
2 |
| Be it enacted by the People of the State of Illinois,
|
3 |
| represented in the General Assembly:
|
4 |
| Section 5. The Code of Criminal Procedure of 1963 is |
5 |
| amended by adding Section 104-17.5 as follows: |
6 |
| (725 ILCS 5/104-17.5 new) |
7 |
| Sec. 104-17.5. Fitness for trial; administration of |
8 |
| authorized involuntary medication upon application to a court. |
9 |
| (a) Generally. Involuntary medication may be administered |
10 |
| to an adult defendant without the informed consent of the |
11 |
| defendant by order of the circuit court pursuant to the |
12 |
| procedures and standards set forth in this Section. |
13 |
| Notwithstanding any other provisions of this Section, a |
14 |
| defendant in the custody of the Department of Human Services |
15 |
| may also be administered medication as provided in the Mental |
16 |
| Health and Developmental Disabilities Code. A defendant in the |
17 |
| custody of the Department of Corrections may also be |
18 |
| administered medication as provided in the rules and |
19 |
| regulations of the Department of Corrections. |
20 |
| (b) Definition. For purposes of this Section, "authorized |
21 |
| involuntary medication" means: |
22 |
| (1) Psychotropic medication whose use for |
23 |
| anti-psychotic, antidepressant, anti-manic, anti-anxiety, |
|
|
|
SB1418 Engrossed |
- 2 - |
LRB095 04444 RLC 24489 b |
|
|
1 |
| behavioral modification, or behavioral management purposes |
2 |
| is listed in the latest edition of the AMA Drug Evaluations |
3 |
| or Physician's Desk Reference or that is administered for |
4 |
| any of these purposes. |
5 |
| (2) Tests and other related procedures that are |
6 |
| essential for the safe and effective administration of a |
7 |
| psychotropic medication. |
8 |
| (c) Petition. The State on behalf of a facility director |
9 |
| may petition the circuit court for an order authorizing the |
10 |
| administration of authorized involuntary medication to a |
11 |
| defendant. The petition shall include: |
12 |
| (1) A copy of the defendant's power of attorney for |
13 |
| health care under the Illinois Power of Attorney Act, a |
14 |
| declaration for mental health under the Mental Health |
15 |
| Treatment Preference Declaration Act, or a statement by the |
16 |
| petitioner that a good faith attempt was made to determine |
17 |
| whether such instruments exist and that none were found to |
18 |
| exist. |
19 |
| (2) A treatment plan with diagnosis, proposed |
20 |
| medications and their dosages and side effects, any |
21 |
| alternative medications and their dosages and side |
22 |
| effects, testing and procedures essential for the safe and |
23 |
| effective administration of the authorized involuntary |
24 |
| medication, and the staff members responsible for |
25 |
| implementing the treatment plan. |
26 |
| (3) If applicable, specific testing and procedures |
|
|
|
SB1418 Engrossed |
- 3 - |
LRB095 04444 RLC 24489 b |
|
|
1 |
| sought to be administered and a request that the court |
2 |
| authorize such testing and procedures as may be essential |
3 |
| for the safe and effective administration of the authorized |
4 |
| involuntary medication sought to be administered. |
5 |
| (4) A statement that other, less restrictive services |
6 |
| have been explored and found inappropriate or, taking |
7 |
| account of less intrusive alternatives, the authorized |
8 |
| involuntary medication is necessary to render the |
9 |
| defendant fit. |
10 |
| If the defendant is in the custody of the Department of |
11 |
| Human Services, the statement shall include a statement that |
12 |
| the defendant was evaluated and could not be medicated under |
13 |
| Section 2-102, 2-107, or 2-107.1 of the Mental Health and |
14 |
| Developmental Disabilities Code. |
15 |
| (d) Service of petition and notice. No later than 7 days |
16 |
| prior to the date of the hearing, the petitioner shall deliver |
17 |
| a copy of the petition and notice of the time and place of the |
18 |
| hearing to the defendant, his or her attorney, any known agent |
19 |
| or attorney-in-fact, if any, and the guardian, if any. Service |
20 |
| may be made by facsimile transmission, mail, or in person. Upon |
21 |
| receipt of the petition and notice, the party served, or the |
22 |
| person delivering the petition and notice to the party served, |
23 |
| shall acknowledge service. If the sending party does not |
24 |
| receive acknowledgment of service within 24 hours, service must |
25 |
| be made by personal service. |
26 |
| (e) Hearing. The court shall hold a hearing within 14 days |
|
|
|
SB1418 Engrossed |
- 4 - |
LRB095 04444 RLC 24489 b |
|
|
1 |
| after the filing of the petition. The People or the petitioner |
2 |
| shall be entitled to a continuance of not more than 7 days as |
3 |
| of right. An additional continuance of not more than 7 days may |
4 |
| be granted to any party (i) upon a showing that the continuance |
5 |
| is needed in order to adequately prepare for or present |
6 |
| evidence in a hearing under this Section or (ii) under |
7 |
| exceptional circumstances. The court may grant an additional |
8 |
| continuance not to exceed 21 days when, in its discretion, the |
9 |
| court determines that such a continuance is necessary to |
10 |
| provide the defendant an examination, a trial by jury, or |
11 |
| substitution of counsel as provided for by the Illinois Supreme |
12 |
| Court Rules. |
13 |
| (f) Evidence. Authorized involuntary medication shall not |
14 |
| be administered to the defendant unless it has been determined |
15 |
| by clear and convincing evidence that all of the following |
16 |
| factors are present: |
17 |
| (1) The defendant has a serious mental illness or |
18 |
| developmental disability. |
19 |
| (2) The authorized involuntary medication is medically |
20 |
| appropriate. |
21 |
| (3) The authorized involuntary medication is |
22 |
| substantially likely to render the defendant fit to stand |
23 |
| trial. |
24 |
| (4) The authorized involuntary medication is |
25 |
| substantially unlikely to have side effects that may |
26 |
| undermine the fairness of the trial. |
|
|
|
SB1418 Engrossed |
- 5 - |
LRB095 04444 RLC 24489 b |
|
|
1 |
| (5) Other, less restrictive services have been |
2 |
| explored and found inappropriate or, taking account of less |
3 |
| intrusive alternatives, the authorized involuntary |
4 |
| medication is necessary significantly to further important |
5 |
| governmental trial-related interests (seriousness of |
6 |
| charge, need for timely adjudication of guilt, and risk of |
7 |
| unadjudicated release if not tried). |
8 |
| (6) If the petition seeks authorization for testing and |
9 |
| other procedures, such testing and procedures are |
10 |
| essential for the safe and effective administration of the |
11 |
| medication. |
12 |
| (g) Order. An order issued under this Section shall |
13 |
| designate the persons authorized to administer the authorized |
14 |
| involuntary medication under the standards and procedures of |
15 |
| this Section. Those persons shall have complete discretion not |
16 |
| to administer any medication authorized under this Section. The |
17 |
| order shall also specify the medication and the anticipated |
18 |
| range of dosages that have been authorized and may include a |
19 |
| list of any alternative medications and range of dosages deemed |
20 |
| necessary. Alternatively, the court may order the proposed |
21 |
| treatment plan that was presented in the petition. |
22 |
| (h) Duration of order. In no event shall an order issued |
23 |
| under this Section be effective for more than 90 days. A second |
24 |
| 90-day period of involuntary medication may be authorized |
25 |
| pursuant to this Section. Thereafter, additional 180-day |
26 |
| periods of involuntary medication may be authorized pursuant to |
|
|
|
SB1418 Engrossed |
- 6 - |
LRB095 04444 RLC 24489 b |
|
|
1 |
| the standards and procedures of this Section without limit. If |
2 |
| a new petition is filed at least 15 days prior to the |
3 |
| expiration of the prior order and the defendant agrees to a |
4 |
| hearing continuance, the administration of the medication may |
5 |
| continue in accordance with the prior order pending the |
6 |
| completion of a hearing under this Section.
|
7 |
| Section 99. Effective date. This Act takes effect upon |
8 |
| becoming law.
|